Suboptimal Baseline Serum Vitamin B12 Is Associated With Cognitive Decline in People With Alzheimer’s Disease Undergoing Cholinesterase Inhibitor Treatment
ObjectivesCholinesterase inhibitors (ChEIs) are the mainstream treatment for delaying cognitive decline in Alzheimer’s disease (AD). Low vitamin B12 is associated with cognitive dysfunction, and its supplementation has been applied as the treatment for certain types of reversible dementia. The prese...
Main Authors: | Hsiao Shan Cho, Li Kai Huang, Yao Tung Lee, Lung Chan, Chien Tai Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fneur.2018.00325/full |
Similar Items
-
Systematic Review of Cholinesterase Inhibitors on Cognition and Behavioral Symptoms in Patients of Chinese Descent with Alzheimer’s Disease, Vascular Dementia, or Mixed Dementia
by: Ka-Chun Leung, et al.
Published: (2017-08-01) -
Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment
by: Jung-Min Pyun, et al.
Published: (2021-01-01) -
Validation of a modified Chinese version of Mini‐Addenbrooke's Cognitive Examination for detecting mild cognitive impairment
by: Feng‐Feng Pan, et al.
Published: (2022-01-01) -
Potential revival of cholinesterase inhibitors as drugs in veterinary medicine
by: Neža Žnidaršič, et al.
Published: (2023-03-01) -
Evaluating Age-related Cognitive performance; An Observational Pilot Study
by: Aiman Khan, et al.
Published: (2020-10-01)